Sangamo Therapeutics
SGMO
#9277
Rank
NZ$0.18 B
Marketcap
NZ$0.45
Share price
2.83%
Change (1 day)
-64.02%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -NZ$0.19 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are NZ$32.87 Million. In 2024 the company made an earning of -NZ$0.17 Billion, an increase over its 2023 earnings that were of -NZ$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.19 Billion12.51%
2024 -NZ$0.17 Billion-17.27%
2023 -NZ$0.21 Billion-40.88%
2022 -NZ$0.35 Billion9.79%
2021 -NZ$0.32 Billion41.52%
2020 -NZ$0.23 Billion23.17%
2019 -NZ$0.18 Billion36.33%
2018 -NZ$0.14 Billion36.89%
2017 -NZ$96.16 Million-22.32%
2016 -NZ$0.13 Billion54.86%
2015 -NZ$79.95 Million75.62%
2014 -NZ$45.53 Million0.13%
2013 -NZ$45.47 Million
2011 -NZ$61.12 Million43.66%
2010 -NZ$42.55 Million28.52%
2009 -NZ$33.11 Million-23.55%
2008 -NZ$43.3 Million2.45%
2007 -NZ$42.27 Million19.5%
2006 -NZ$35.37 Million50.78%
2005 -NZ$23.46 Million75%
2004 -NZ$13.41 Million-33.25%
2003 -NZ$20.08 Million-62.27%
2002 -NZ$53.23 Million102.82%
2001 -NZ$26.24 Million23.21%
2000 -NZ$21.3 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$57.24 B-30,874.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.31 B-8,332.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$2.65 B-1,527.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-NZ$4.29 Billion 2,203.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$16.71 B-9,085.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$38.25 B-20,666.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$0.98 B-628.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.82 B-542.54%๐Ÿ‡บ๐Ÿ‡ธ USA